Lawrence A. Leiter

Researcher Next ID · RN-004140

Researcher · Medicine

Toronto, Canada

Not currently recruitingFunding unknown

Research interests

Medicine

Diabetes Treatment and Management

Lipoproteins and Cardiovascular Health

Diabetes, Cardiovascular Risks, and Lipoproteins

Diabetes Management and Research

Diet and metabolism studies

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)31149-3
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1812389
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)32590-x
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1607141
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1307684

No projects listed.